FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDRH to Complete Essure Safety Review in February

[ Price : $8.95]

CDRH says it will complete a safety review of Bayer Healths controversial Essure permanent birth control device by the end of Febr...

State Versus Federal Drug Rule in 2 Court Cases

[ Price : $8.95]

New York University law professor Catherine Sharkey describes two recent court cases that explore the tension between federal and ...

PDUFA 6 Sub-groups Report

[ Price : $8.95]

Five PDUFA 6 Reauthorization Steering Committee sub-groups report on their discussions and progress at the 10/20 steering committe...

IRB Minutes Guidance Explained

[ Price : $8.95]

Four Quarles & Brady attorneys summarize provisions of a new FDA guidance on institutional review board minutes.

CGMP Violations at Two Sandoz India Plants

[ Price : $8.95]

FDA warns Sandoz Private Limited about CGMP problems found at two drug manufacturing facilities in India.

Another Senator Opposes Califfs Nomination

[ Price : $8.95]

U.S. senator Lisa Murkowski (R-AK) says she will oppose Robert Califfs nomination to become the next FDA commissioner due to the a...

FDA Releases Dr. Reddys Warning Letter

[ Price : $8.95]

FDA releases its 11/5 Warning Letter to Dr. Reddys Laboratories detailing findings from inspections at three of the companys facil...

FDA Guidance on Medical Gas Certification Under FDASIA

[ Price : $8.95]

FDA posts a draft guidance on Certification Process for Designated Medical Gases that explains how the agency administers the cert...

FDA Approves Lilly Lung Cancer Drug

[ Price : $8.95]

FDA approves an Eli Lilly NDA for Portrazza (necitumumab) and its use in combination with two forms of chemotherapy to treat patie...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites A-1 Engineering, Advanced Physician Solutions, Inc., d/b/a Advanced Compounding ...